Literature DB >> 10779247

Nightmares and disorders of dreaming.

J F Pagel1.   

Abstract

Dreams occur during all stages of sleep. Nightmares are common. They can be associated with poor sleep and diminished daytime performance. Frequent nightmares are not related to underlying psychopathology in most children and in some "creative" adults. However, recurrent nightmares are the most defining symptom of post-traumatic stress disorder and may be associated with other psychiatric illnesses. Night terrors are arousal disorders that occur most often in children and usually occur early in the sleep period. Patients with rapid-eye-movement behavior disorder often present with nocturnal injury resulting from the acting out of dreams. Dream disorders may respond to medication, but behavioral treatment approaches have shown excellent results, particularly in patients with post-traumatic stress disorder and recurrent nightmares.

Entities:  

Mesh:

Year:  2000        PMID: 10779247

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  5 in total

1.  Medications for the Treatment of Sleep Disorders: An Overview.

Authors:  J F Pagel; Bennett L. Parnes
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-06

Review 2.  Sleep disorders and depression: brief review of the literature, case report, and nonpharmacologic interventions for depression.

Authors:  Antonina Luca; Maria Luca; Carmela Calandra
Journal:  Clin Interv Aging       Date:  2013-08-05       Impact factor: 4.458

Review 3.  Differentiating Oneiric Stupor in Agrypnia Excitata From Dreaming Disorders.

Authors:  Luca Baldelli; Federica Provini
Journal:  Front Neurol       Date:  2020-11-12       Impact factor: 4.003

4.  Predictors of dream enactment behavior among medical students: The case of the University of Gondar, Ethiopia.

Authors:  Baye Dagnew; Mengistie Diress; Mihret Getnet; Mohammed Abdu Seid; Sofonias Addis Fekadu; Yibeltal Yismaw Gela; Yigizie Yeshaw; Yitayeh Belsti; Yonas Akalu
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

5.  Centrally acting anticholinergic drug trihexyphenidyl is highly effective in reducing nightmares associated with post-traumatic stress disorder.

Authors:  Katsumasa Sogo; Masanobu Sogo; Yoshie Okawa
Journal:  Brain Behav       Date:  2021-05-14       Impact factor: 2.708

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.